Current Drug Targets
Title:Editorial: “Phytochemicals for Human Diseases: An Update”
Volume: 18 Issue: 13
Author(s): Seyed M. Nabavi and Maria Daglia
Affiliation:
Export Options
About this article
Cite this article as:
Nabavi M. Seyed and Daglia Maria , Editorial: “Phytochemicals for Human Diseases: An Update”, Current Drug Targets 2017; 18 (13) . https://dx.doi.org/10.2174/138945011813170914093338
DOI https://dx.doi.org/10.2174/138945011813170914093338 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Using Functional Neuroimaging to Investigate the Mechanisms of Action of Selective Serotonin Reuptake Inhibitors (SSRIs)
Current Pharmaceutical Design Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research
Current Medicinal Chemistry Current Progress in the Development of HIV Vaccines
Current Pharmaceutical Design Delivery of Anti-Viral Nucleoside Analogues to the Central Nervous System
Current Medicinal Chemistry - Anti-Infective Agents Recent Developments in Delivery of Nucleic Acid-Based Antiviral Agents
Current Pharmaceutical Design A Highlight on Lipid Based Nanocarriers for Transcutaneous Immunization
Current Pharmaceutical Biotechnology Herpes Simplex Virus Vectors for the Nervous System
Current Gene Therapy HIV-1 Tat Protein Exposure Potentiates Ethanol Reward and Reinstates Extinguished Ethanol-Conditioned Place Preference
Current HIV Research Inhibition of RNA Virus Infections with Peptide-Conjugated Morpholino Oligomers
Current Pharmaceutical Design Cytomegalovirus Infections in Non-Immunocompromised and Immunocompromised Patients in the Intensive Care Unit
Infectious Disorders - Drug Targets Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Current Pharmaceutical Design Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Current Pharmaceutical Biotechnology Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins
Current Gene Therapy STING Activation and its Application in Immuno-Oncology
Current Topics in Medicinal Chemistry Vaccines for Cytomegalovirus
Infectious Disorders - Drug Targets Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Occurrence of DAT1 (VNTR) Polymorphism in Individuals with HIV Infection
Current Pharmacogenomics and Personalized Medicine Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Current Genomics Antiviral Herbs - Present and Future
Infectious Disorders - Drug Targets